Explore the NIH's new policy ending federal funding for fetal tissue research from elective abortions and its ethical, scientific, and political...
Vous n'êtes pas connecté
Maroc - NLM.NIH.GOV - NLM News and Events - 18/11/2024 14:57
A team of researchers from NIH’s National Library of Medicine and National Cancer Institute developed an AI algorithm that could successfully identify relevant clinical trials for which a person is eligible and provide a summary that clearly explains how that person meets the criteria for study enrollment. The tool can help make it easier for both clinicians and patients to find and connect with the right clinical trial opportunities.
Explore the NIH's new policy ending federal funding for fetal tissue research from elective abortions and its ethical, scientific, and political...
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest...
The vaccine has been successfully developed, and animal challenge and toxicity studies have been completed ......
Researchers developed criteria for triaging suspected UTIs, focusing on antibiotic use and urine testing to improve outpatient care and telehealth...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...
Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...
Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...
Competitive: Worldwide Clinical Trials - APAC: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...
Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...